Valuation : Abbott Laboratories

Market Cap 187B 161B 152B 138B 259B 17,728B 260B 1,798B 695B 9,079B 704B 689B 28,918B P/E 2026 *
31.1x
P/E 2027 * 23.9x
Enterprise Value 211B 182B 171B 156B 292B 19,992B 293B 2,027B 784B 10,238B 794B 777B 32,611B EV / Sales 2026 *
4.2x
EV / Sales 2027 * 3.81x
Free-Float
86.16%
Yield 2026 *
2.37%
Yield 2027 * 2.53%
6 months-13.99%
Current year-28.49%
1 week 82.66
Extreme 82.66
82.66
1 month 82.66
Extreme 82.66
82.66
3 years 82.66
Extreme 82.66
125.16
Manager TitleAgeSince
Chief Executive Officer 52 2020-03-30
Director of Finance/CFO 53 2023-08-31
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 2011-12-08
Director/Board Member 67 2011-12-08
Director/Board Member 71 2017-02-15
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-28.49%-16.52% 187B
-0.42%-1.84%-18.51%+7.61% 187B
+1.15%+3.88%+1.37%+17.82% 120B
-1.86%+2.27%+13.15%+85.74% 63.15B
-3.40%-6.29%+12.38%+45.24% 52.36B
-1.54%-1.79%-3.98%-30.82% 50.32B
-2.02%-3.47%+9.18%-16.21% 33.17B
0.00%+4.45% - - 32.1B
-0.81%-0.33%+35.59%-15.82% 23.93B
-1.98%-8.57%-12.46%+9.05% 22.7B
Average -1.25%-0.72%+0.91%+9.56% 65.07B
Weighted average by Cap. -0.99%-0.77%-8.77%+8.09%

Financials

2026 *2027 *
Net sales 50.3B 43.26B 40.69B 37.14B 69.46B 4,757B 69.69B 482B 186B 2,436B 189B 185B 7,760B 54.65B 47B 44.2B 40.35B 75.46B 5,168B 75.71B 524B 203B 2,647B 205B 201B 8,430B
Net income 6.23B 5.36B 5.04B 4.6B 8.61B 589B 8.63B 59.77B 23.1B 302B 23.41B 22.89B 961B 7.92B 6.82B 6.41B 5.85B 10.94B 749B 10.98B 76B 29.38B 384B 29.76B 29.11B 1,222B
Net Debt 23.94B 20.59B 19.36B 17.68B 33.06B 2,264B 33.17B 230B 88.74B 1,159B 89.9B 87.94B 3,693B 20.96B 18.02B 16.95B 15.47B 28.94B 1,982B 29.03B 201B 77.69B 1,015B 78.7B 76.98B 3,233B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
-
Date Price Change
26-09-07 €82.66 0.00%
26-09-04 €82.66 0.00%
26-09-03 €82.66 0.00%
26-09-02 €82.66 0.00%
26-09-01 €82.66 0.00%
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
108.33USD
Average target price
120.20USD
Spread / Average Target
+10.96%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!